Funding cuts and regulatory changes could radically reduce Medicaid, the largest program providing medical and health-related ...
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
The directive for the Department of Health and Human Services to develop and test new models aimed at lowering drug costs ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
Medicare and Medicaid are major sources of government spending, yet Democrats and Republicans alike support funding the ...
The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) ...
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...
In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.
Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...